Literature DB >> 8148319

Quantitation of human influenza virus-specific cytotoxic T lymphocytes: correlation of cytotoxicity and increased numbers of IFN-gamma producing CD8+ T cells.

S Di Fabio1, I N Mbawuike, H Kiyono, K Fujihashi, R B Couch, J R McGhee.   

Abstract

To study virus-specific cytotoxic T lymphocyte (CTL) activity at the single cell level, an IFN-gamma specific ELISPOT assay was adapted to elucidate the frequency of influenza-specific CTLs together with a standard cytotoxic 51Cr-release assay. Peripheral blood mononuclear cells (PBMCs) from human volunteers were cultured with influenza virus-infected autologous cells; following 3 or 7 days of culture, T cell subsets were assessed for IFN-gamma production by IFN-gamma-specific ELISPOT and ELISA, while IFN-gamma mRNA expression was determined by reverse transcriptase-polymerase chain reaction (RT-PCR). Influenza virus-specific CTL activity was measured in a 4 h 51Cr-release assay. Culture of PBMC with autologous A/Taiwan influenza (H1N1)-infected stimulator cells resulted in IFN-gamma spot forming cells (SFCs) at 3 days that increased after 7 days of incubation. Numbers of IFN-gamma SFCs directly correlated with levels of secreted IFN-gamma and higher levels were seen in supernatants from 7 day cultures. RT-PCR analysis (35 cycles of amplification) showed greater IFN-gamma mRNA in T cells isolated from 7 day cultures. Separate aliquots of T cells from these cultures were also assessed for virus-specific cytotoxicity and T cells from 7 day (but not from 3 day) cultures induced high 51Cr release. Analysis indicated a significant direct correlation between level of cytotoxicity, number of IFN-gamma SFCs, and amount of IFN-gamma in culture supernatants. Studies with purified T cell subsets showed that elevated IFN-gamma SFCs, IFN-gamma synthesis, and cytotoxic activity were associated with CD4-CD8+ T cells but not with the CD4+CD8- T cell subset.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8148319     DOI: 10.1093/intimm/6.1.11

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  12 in total

Review 1.  Heterogeneous memory T cells in antiviral immunity and immunopathology.

Authors:  David Verhoeven; John R Teijaro; Donna L Farber
Journal:  Viral Immunol       Date:  2008-06       Impact factor: 2.257

2.  Memory CD4 T cells direct protective responses to influenza virus in the lungs through helper-independent mechanisms.

Authors:  John R Teijaro; David Verhoeven; Carly A Page; Damian Turner; Donna L Farber
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

3.  Transfer of influenza vaccine-primed costimulated autologous T cells after stem cell transplantation for multiple myeloma leads to reconstitution of influenza immunity: results of a randomized clinical trial.

Authors:  Edward A Stadtmauer; Dan T Vogl; Eline Luning Prak; Jean Boyer; Nicole A Aqui; Aaron P Rapoport; Kenyetta R McDonald; Xiaoling Hou; Heather Murphy; Rita Bhagat; Patricia A Mangan; Anne Chew; Elizabeth A Veloso; Bruce L Levine; Robert H Vonderheide; Abbas F Jawad; Carl H June; Kathleen E Sullivan
Journal:  Blood       Date:  2010-09-23       Impact factor: 22.113

4.  Immunologic consequences of chemotherapy for acute myeloid leukemia.

Authors:  Anne Reilly; Leslie S Kersun; Eline Luning Prak; Jean Boyer; Kenyetta McDonald; Abbas F Jawad; Kathleen E Sullivan
Journal:  J Pediatr Hematol Oncol       Date:  2013-01       Impact factor: 1.289

5.  Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach.

Authors:  J Talon; M Salvatore; R E O'Neill; Y Nakaya; H Zheng; T Muster; A García-Sastre; P Palese
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

6.  Development of an epitope panel for consistent identification of antigen-specific T-cells in humans.

Authors:  Andreas Fløe; Caroline Løppke; Ole Hilberg; Christian Wejse; Liselotte Brix; Kivin Jacobsen
Journal:  Immunology       Date:  2017-07-03       Impact factor: 7.397

7.  Immunologic consequences of chemotherapy for ovarian cancer: impaired responses to the influenza vaccine.

Authors:  Christina S Chu; Jean D Boyer; Abbas Jawad; Kenyetta McDonald; Wade T Rogers; Eline T Luning Prak; Kathleen E Sullivan
Journal:  Vaccine       Date:  2013-09-13       Impact factor: 3.641

8.  A prospective study of influenza vaccination and a comparison of immunologic parameters in children and adults with chromosome 22q11.2 deletion syndrome (digeorge syndrome/velocardiofacial syndrome).

Authors:  Abbas F Jawad; Eline Luning Prak; Jean Boyer; Donna M McDonald-McGinn; Elaine Zackai; Kenyetta McDonald; Kathleen E Sullivan
Journal:  J Clin Immunol       Date:  2011-08-24       Impact factor: 8.317

9.  Cooperativity between CD8+ T cells, non-neutralizing antibodies, and alveolar macrophages is important for heterosubtypic influenza virus immunity.

Authors:  Brian J Laidlaw; Vilma Decman; Mohammed-Alkhatim A Ali; Michael C Abt; Amaya I Wolf; Laurel A Monticelli; Krystyna Mozdzanowska; Jill M Angelosanto; David Artis; Jan Erikson; E John Wherry
Journal:  PLoS Pathog       Date:  2013-03-14       Impact factor: 6.823

10.  Cationic liposome-mediated enhanced generation of human HLA-restricted RSV-specific CD8+ CTL+.

Authors:  Innocent N Mbawuike; Yongxin Zhang; Ying Wang; Ling Song
Journal:  J Clin Immunol       Date:  2002-05       Impact factor: 8.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.